Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H5N8-MF59 avian influenza vaccine blood sampling study
ISRCTN46278228Phase 4Active, not recruiting
- Sponsor
- St George's, University of London
- Start
- Aug 2026
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 4, open-label, single-arm trial of CSL404 in Avian Influenza (AI), sponsored by St George's, University of London. Primary endpoint: Volume of blood samples sent to UKHSA for storage and future analysis. Started Aug 2026; status: active, not recruiting.
02
Drugs
CSL404
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on ISRCTN46278228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN46278228.